Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated core content to reflect a new version (v3.2.0) and a government funding-related operating-status notice; the previous version tag (v3.1.0) was removed.SummaryDifference13%

- Check28 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check42 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; no other core content changes are evident. The removal of 'Back to Top' is a minor UI change.SummaryDifference0.8%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.8%

- Check57 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference7%

- Check71 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.